7
Apr

Long-term aspirin use associated with reduced risk of dying from cancer, study shows

Long-term use of aspirin is associated with lower risk of dying from various types of cancers, including colorectal, lung, breast and prostate cancer, according to a study presented at the 2017 American Association for Cancer Research Annual Meeting on Monday.

The longitudinal study analyzed the association of aspirin, with varied doses and duration of use, on overall mortality risks and mortality risks from cancer over a nearly 32-year period. Previous studies have shown that aspirin prevents cardiovascular disease and some types of cancer, particularly colorectal cancer, and seems to reduce the risk of dying from cancer. This large study with long-term follow-up was one of the first to examine the potential benefits of different doses and durations of aspirin use.

Read Full Story Here >>